Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
BIO logo

BIO

NYE
Bio-Rad Laboratories Inc. Class A
Healthcare•Diagnostics & Research
Watchlists:
Last updated: Monday 14th July 2025
256.97
-2.91 (-1.12%)
Prev Close:259.88
Open:257.28
Bid:207.93
Ask:271.07
52 Week Range
211.43
387.99
Volume:342,866
Mkt Cap:6,823 M
61
MarketXLS Rank ®
Buy
How are these ranks calculated?
Price Target
$295.52
+15.0%
overviewOptionfinancialsvaluequalitytechnicalestimatespeersnewsTrend Analysis & Forecastdata
Metrics

Valuation

Returns

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Dividends

Analyst Estimates

Financial Health

Cash Metrics
Liquidity Ratios
Debt Metrics
Other Metrics
Financial Scores

Technicals

Technical Oscillators
Moving Averages
Volatility Metrics

Profitability

Financials

Financial Statements

BIO - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-15
Depreciation And Amortization152 M146 M137 M138 M-37 M-40 M-138 M-149 M-143 M-132 M
Gain On Sale Of Business-1 M1 M-900000.0-1 M-400000.0
Gain On Sale Of PPE1 M12 M5 M-8 M-600000.0-300000.0
Gain On Sale Of Security2 M8 M4,496 M2,031 M606 M7 M800000.02 M
General And Administrative Expense814 M842 M828 M877 M-47 M-44 M-44 M-45 M
Gross Profit Margin (profit Margin After CGS)1,379 M1,427 M1,567 M1,638 M1,438 M-1,055 M-1,066 M-972 M1,138 M1,122 M
Impairment Of Capital Assets293 M12 M62 M
Interest Expense Non Operating49 M49 M38 M2 M22 M23 M24 M23 M22 M22 M
Misc Other Special Charges90 M107 M45 M27 M2,570 M2,338 M2,326 M2,171 M15 M11 M
Net Income (loss)-1,844 M-637 M-3,628 M4,254 M3,814 M1,759 M366 M122 M26 M113 M
Net Income Common Stockholders-1,844 M-637 M-3,628 M4,254 M3,814 M1,759 M366 M122 M26 M113 M
Net Income Continuous Operations-1,844 M-637 M-3,628 M4,254 M3,806 M1,759 M366 M122 M26 M113 M
Net Non Operating Interest Income Expense-49 M-49 M-20 M-2 M-22 M-23 M-24 M-23 M-22 M-22 M
Non Recurring Operation Expense-35 M-141608.0-141608.0-141608.0
Operating Income269 M338 M483 M500 M-2,135 M-2,082 M-2,100 M-2,029 M115 M167 M
Operating Income Before Depreciation (EBITDA)-2,294 M-655 M-4,529 M5,588 M5,078 M2,244 M537 M121 M64 M168 M
Operating Expense1,110 M1,089 M1,092 M1,138 M1,027 M1,027 M1,034 M1,057 M1,023 M955 M
Other Gand A814 M842 M828 M877 M-47 M-44 M-44 M-45 M
Other Impairment Of Capital Assets12 M800000.0-5 M-6 M-800000.0-7 M-46 M
Other Operating Expenses-10 M-18 M-45 M-51 M-5 M-35 M-3 M-1 M
Other Write Off-2 M-1 M-2 M-7 M
Rent And Landing Fees-47 M-44 M-44 M-45 M
Research Expense296 M247 M257 M261 M227 M203 M199 M250 M206 M193 M
Restructring And Mn A Income4 M-11 M-12 M
Salaries And Wages-9 M-7 M-42 M-36 M-28 M-23 M-20 M-17 M
Selling And Marketing Expense800 M825 M835 M807 M817 M762 M
Selling Expense800 M825 M835 M807 M817 M762 M
Total Income Available For Interest Expense (EBIT)-2,294 M-801 M-4,666 M5,451 M4,940 M2,284 M537 M121 M64 M168 M
Total Revenues2,567 M2,671 M2,802 M2,923 M2,546 M2,312 M2,289 M2,160 M2,068 M2,019 M
Total Expenses2,298 M2,333 M2,327 M2,422 M2,135 M2,082 M2,100 M2,029 M1,953 M1,853 M
Total Revenue2,567 M2,671 M2,802 M2,923 M2,546 M2,312 M2,289 M2,160 M2,068 M2,019 M
Write Down-1 M
Amord411 M414 M407 M346 M-29 M-24 M-27 M-29 M-33 M-36 M
Avgshs28 M29 M30 M30 M30 M30 M30 M30 M29 M29 M
Avgshsdt28 M29 M30 M30 M30 M30 M30 M30 M30 M29 M
Basiceps-65.36-21.82-121.79142.33127.8658.9312.254.120.883.87
Basicepscont-65.36-21.82-121.79142.33
Cor1,188 M1,244 M1,235 M1,284 M1,108 M1,055 M1,066 M972 M930 M898 M
Depamor137 M138 M-138 M-134 M-138 M-149 M-143 M-132 M
Dileps-65.36-21.82-121.79140.56126.258.2712.14.070.883.85
Dilepscont-21.82-121.79140.56
Netincdisc-1,844 M-637 M-3,628 M4,254 M3,814 M1,759 M366 M122 M26 M113 M
Othincexp2,567 M1,146 M-5,199 M-4,953 M-7,066 M-4,369 M-2,932 M-2,171 M-15 M-11 M
Pretaxinc-2,342 M-850 M-4,704 M5,449 M4,908 M2,261 M513 M98 M42 M146 M
Resdev296 M247 M257 M261 M227 M203 M199 M250 M206 M193 M
Restruct4 M-11 M-12 M
Sga814 M842 M828 M877 M800 M825 M835 M807 M817 M762 M
Shsout28 M29 M30 M30 M30 M30 M30 M30 M30 M29 M
Specincchg-28 M-4 M11 M35 M-293 M-12 M-62 M
Taxprov-498 M-213 M-1,077 M1,195 M1,104 M502 M147 M-24 M16 M33 M
<< PREVIOUS STOCK
NEXT STOCK>>
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

•

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

•

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

•

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

•

Professional Trader